Eucrisa and Omeprazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Eucrisa (crisaborole) and Omeprazole (omeprazole). Common drug interactions include eye pain among females and rash among males.

The phase IV clinical study analyzes what interactions people have when they take Eucrisa and Omeprazole. It is created by eHealthMe based on reports of 93 people who take the same drugs from the FDA, and is updated regularly.

What is Eucrisa?

Eucrisa has active ingredients of crisaborole. eHealthMe is studying from 9,900 Eucrisa users. Check the latest studies of Eucrisa.

What is Omeprazole?

Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 410,631 Omeprazole users. Check the latest studies of Omeprazole.

On Jul, 09, 2026

93 people who take Eucrisa and Omeprazole together, and have interactions are studied.

Eucrisa and Omeprazole drug interactions.

What are the common drug interactions of Eucrisa and Omeprazole, by gender? *:

female:

Eye pain
Sinusitis (inflammation of sinus)
Therapeutic response unexpected
Upper respiratory tract infection
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Ankle fracture
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Blood pressure increased
Dyspnoea (difficult or laboured respiration)
Full blood count decreased

male:

Rash
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
Chest pain
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Contusion (a type of hematoma of tissue in which capillaries)
Cough
Dehydration (dryness resulting from the removal of water)
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Disease progression

What are the common drug interactions of Eucrisa and Omeprazole, by age (0-1 to 60+)? *:

0-1:

Adverse drug reaction
Dyspnoea (difficult or laboured respiration)
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Erythema (redness of the skin)
Insomnia (sleeplessness)
Irritability
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Rash
Skin haemorrhage (bleeding into skin)
Upper respiratory tract inflammation

2-9:

Ear infection
Ear pain
Nausea (feeling of having an urge to vomit)
Otorrhoea (discharge from the ear)
Pain
Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
Respiratory tract infection
Sinusitis (inflammation of sinus)
Tenderness (pain or discomfort when an affected area is touched)
Tooth extraction

10-19:

Anaphylactic reaction (serious allergic reaction)
Angioedema (rapid swelling of the dermis)
Chest pain
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
Eosinophil count increased
Immune system disorder
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Ocular hyperaemia (an abnormally large amount of blood in eye)
Skin mass
Troponin increased

20-29:

Inflammation
Rash macular (small, flat red spots)

30-39:

Injection site bruising
Pneumonia
Asthma
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Cough
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Eczema herpeticum (feverish condition and widespread eruption of vesicles)
Fatigue (feeling of tiredness)

40-49:

Rash
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Erythema (redness of the skin)
Asthma
Drug ineffective
Influenza
Injection site reaction
Pruritus (severe itching of the skin)
Sleep disorder
Surgery

50-59:

Limb injury
Oedema (fluid collection in tissue)
Oesophageal discomfort (pain or burning feeling behind breast bone)
Pruritus (severe itching of the skin)
Slow speech
Weight increased
Back disorder
Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
Infusion site extravasation (flow of (blood or lymph) from infusion site)
Joint injury

60+:

Pruritus (severe itching of the skin)
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Back pain
Blood pressure increased
Body height decreased
Chills (felling of cold)
Drug hypersensitivity
Dry skin
Dyspnoea (difficult or laboured respiration)
Fall

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 43 people, 46.24%
Immunodeficiency Common Variable: 8 people, 8.60%
Asthma: 7 people, 7.53%
Lichen Myxoedematosus (deposition of acid mucopolysaccharides in the skin): 6 people, 6.45%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 6 people, 6.45%
Pain: 5 people, 5.38%

* Approximation only. Some reports may have incomplete information.

Do you take Eucrisa and Omeprazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously